Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
Medical Darpan Media House is the fastest growing health & pharma news portal in India. Stay tuned to read all the authentic latest updates in Pharma Industry. Now read in Hindi also.
Latest in Pharmaceuticals : Sleep Drug: MK-4305 and Plastic AntibodiesAmna Adnan
WALTHAM, Mass., Nov. 15, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that the U.S. Food and Drug Administration (FDA) has approved Revuforj (revumenib) as the first and Latest NewsNDA News247 2024/11/19•Read All ...
Panuveitis Market Expected to Grow at a CAGR Of 7.55% During 2025-2035, impelled by Advancements in Innovative Therapies February 7, 2025 · 10 min read Press Releases Neurocutaneous Syndromes Market Expected to Exhibit a CAGR of 6.69% During 2025-2035, Impelled by Increasing Awareness and Early...
Pharmacogenetics, related to pharmacology, is the study of the genetic variation between individuals that affects their response to drugs/pharmaceuticals and other xenobiotics, both therapeutically and in terms of adverse effects (side effects). Personalized medicine is the use of pharmacogenetics to under...
View our CNBC video gallery to find news clips on the stock market and more! Play live videos and find up to date market news. Break down your selection by: Top Videos, Most Viewed, US, Europe, Asia, Analyst Interviews, CEO Interviews.
Get all the latest news about pharmaceutical stocks across the world. Stay up to date with everything affecting pharmaceutical stock prices so you can invest your money wisely
BRIDGEWATER, N.J.--(BUSINESS WIRE) August 7, 2024 -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approv Latest NewsNDA News483
Pharmaceuticals News, Analysis and Opinion from POLITICO Facebook X 2025 Presidential Transition A world without seed oils and pesticides? The food industry braces for RFK Jr. era. Kamala Harris 2024 Washington’s most powerful interests don’t know whether to cheer Harris — or dread her...